A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

NCT01237678 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
181
Enrollment
INDUSTRY
Sponsor class

Stopped Study was stopped early due to lack of efficacy signal and safety concerns

Conditions

Interventions

Sponsor

ImmunoGen, Inc.